WE PRESENT A simple risk prediction formula for arteriovenous malformation hemorrhage. Natural history studies have shown an annual risk of hemorrhage of 2 to 4% for patients with brain arteriovenous malformations. Although decision analysis programs and biostatistical models are available to predict long-term risks of hemorrhage, we hypothesized that there was varying knowledge regarding the use of such programs within the general neurosurgical community. To obtain information on the current use of risk data, we performed a survey of neurosurgeons at national meetings in 1988 and 1994. Neurosurgeons were asked to define the risk for arteriovenous malformation hemorrhage in the young adult patient over a 20-to 30-year period, given a 3 or 4% annual risk of hemorrhage. A wide range of answers was obtained (1-100% risk), and many different methods of calculation were used. The use of the multiplicative law of probability formula requires only knowledge of patient age and annual hemorrhage risk. Risk of hemorrhage = 1 -(risk of no hemorrhage)expected years of remaining lifc. The assumptions pertaining to this multiplicative formula include a constant yearly risk of hemorrhage and the independent behavior of all years of observation. We calculated the predictions of risk of hemorrhage across all age groups, as modified by published survival data. We think the use of this formula is justified by published natural history data across different ages and populations and that it is a simple and reasonable alternative to other methods of calculation. (Neurosurgery 37:851-855, 1995) Key words: Arteriovenous m alform ation, Hemorrhage, Hemorrhage risk, Natural history the ways in which they use published natural history data (usually stated as an annual risk of bleeding) to advise pa tients about their long-term (lifetime) prognosis; and 2) to propose a simple formula for calculating the risk of subse quent bleeding over a prolonged period of time, based on the multiplicative law of probability (5). This formula requires a number of assumptions and, as proposed, does not take into account some of the published risk factors for subsequent bleeding, but it is simple to use and may be a reasonable alternative for clinical use. , The problems with such an approach to risk estimation include population heterogeneity, a variable natural history, and the existence of patient sub-groups with different risks for initial and subsequent hemorrhage (e.g., pregnant women, patients with AVMs and aneurysms, patients with AVMs with venous outflow restriction) (3, 13, 19, 23, 26, 31, 33, 34) . Although the estimated 2 to 4% yearly risk of hemorrhage has been substantiated in different countries and appears not to vary significantly through the course of follow-up, indicating R ecent studies have agreed that the annual risk for hem orrhage from a brain arteriovenous malformation (AVM) is ~2 to 4% (4, 6, 11, 12, 16, 17, 24, 25) . This is useful information, but it needs to be used by surgeons to advise patients about the risk of bleeding over a number of years or over the remainder of their lives. One alternative is for the surgeon to inform the patient of a 2 to 4% risk per year. The interpretation of that figure is then left up to the patient. Most surgeons are asked for or think that they should provide the patient with a summary of the risk over a longer time period to give them a more representative idea of the natural history. Such information is often used as the basis for a decision to treat an AVM, along with expected treatment risks (29, 30). A decision analysis model has been published; it takes into account a number of risk factors and the patients' perception of the possible outcomes (9). This appears to be a good model, but it may be difficult to apply in day-to-day clinical situations. The two purposes of our study were as follows: 1) to survey practicing neurosurgeons and examine
the ways in which they use published natural history data (usually stated as an annual risk of bleeding) to advise pa tients about their long-term (lifetime) prognosis; and 2) to propose a simple formula for calculating the risk of subse quent bleeding over a prolonged period of time, based on the multiplicative law of probability (5) . This formula requires a number of assumptions and, as proposed, does not take into account some of the published risk factors for subsequent bleeding, but it is simple to use and may be a reasonable alternative for clinical use. , The problems with such an approach to risk estimation include population heterogeneity, a variable natural history, and the existence of patient sub-groups with different risks for initial and subsequent hemorrhage (e.g., pregnant women, patients with AVMs and aneurysms, patients with AVMs with venous outflow restriction) (3, 13, 19, 23, 26, 31, 33, 34). Although the estimated 2 to 4% yearly risk of hemorrhage has been substantiated in different countries and appears not to vary significantly through the course of follow-up, indicating R ecent studies have agreed that the annual risk for hem orrhage from a brain arteriovenous malformation (AVM) is ~2 to 4% (4, 6, 11, 12, 16, 17, 24, 25). This is useful information, but it needs to be used by surgeons to advise patients about the risk of bleeding over a number of years or over the remainder of their lives. One alternative is for the surgeon to inform the patient of a 2 to 4% risk per year. The interpretation of that figure is then left up to the patient. Most surgeons are asked for or think that they should provide the patient with a summary of the risk over a longer time period to give them a more representative idea of the natural history. Such information is often used as the basis for a decision to treat an AVM, along with expected treatment risks (29, 30). A decision analysis model has been published; it takes into account a number of risk factors and the patients' perception of the possible outcomes (9). This appears to be a good model, but it may be difficult to apply in day-to-day clinical situations. The two purposes of our study were as follows: 1) to survey practicing neurosurgeons and examine some degree of population homogeneity and predictable nat ural history, the interpretation of population data to specific patients must be approached with caution. It is not our pur pose to use this formula and its assumptions to derive hem orrhage rates that represent mathematical fact but rather to derive rates that are reasonable, easy to use, and make sense with previously published clinical studies.
METHODS

The proposed method of calculation
If we assume that the annual risk of bleeding is 3% (0.03), then the chance of remaining free of hemorrhage for 1 year is 1 -0.03 = 0.97. The chance of remaining hemorrhage-free for 2 years is calculated by applying the multiplicative law of probability (5) as follows: 0.97 X 0.97 = 0.94. The chance of having no bleeds for y years = 0.97y.
Patients will be at risk of subsequent bleeding for the rest of their lives. Based on the age of presentation, a patient's "expected years of remaining life" can be determined from life tables (1). Thus, the patients' cumulative chance of staying hemorrhage-free for life is equal to the following: 0.97e*pected y8ars of ufe or the risk of bleeding (at least OnCG) = 1_0 9 Mortality from bleeding does not affect this calculation. We are calculating the probability of remaining free of bleeds over a period of time, and we are assuming that each year the probability of not bleeding is 0.97. Among the 0.03 patients who have: bled, some (~5-20%) will die but this will not affect the proportion who are alive and hemorrhage-free at the end of the 1st year and remain at risk. The probability of living and not bleeding over x years then is 0.97* and the probability of bleeding (whether or not death occurs from the bleed) = 1 -0.97*. 
A survey of neurosurgeons
RESULTS
The application of the formula
Risk estimates for patients from birth to age 85 years are calculated (assuming an annual risk of 3 or 4%) and presented in Table 1 .
The surveys
In 1988, 16 individuals were surveyed. Eight were resi dents, and eight were attending neurosurgeons. One surgeon (6%) estimated the risk to be 60%. Three "guessed" at the risk and gave answers from 50 to 80%. Six respondents gave very high risks of 90 to 100%, and two answered 30%. Four gave no response. Using the multiplicative law of probability, the risk of hemorrhage is calculated to be 60%. In the 1994 survey, 103 neurosurgeons were sampled. Twenty-eight of the total respondents were resident neuro surgeons, 72 were attending neurosurgeons, and 3 did not provide their level of training status. Eight individuals (8%) said they would use the multiplicative law of probability or gave a risk of 56%. They were equally distributed between residents and attending neurosurgeons. Twenty-four sur geons (23%) provided a "guess" between 50 and 79%. Fifty surgeons (49%) calculated an 80% total risk by multiplying a 4% per year risk by 20 years. Five surgeons (5%) calculated 4% as the total risk for hemorrhage. Fifteen (15%) surgeons pro vided a range of answers between 1 and 49% risk or greater than 80% risk, and one surgeon provided no answer. Using the multiplicative law of probability, the risk in this survey is calculated to be 56%. We considered a close answer to be within 25% of that calculated; this was provided by 18% of the surgeons.
DISCU SSIO N
The effort put forth by numerous institutions to understand the natural history of untreated AVMs has provided consis tent information. The annual risk of hemorrhage from an untreated or incompletely obliterated AVM was found to be between 2 and 4% per year (4, 24). These natural history rates of subsequent bleeds are the basis for making management decisions. We were interested in the way surgeons used this information when talking to a hypothetical patient. In both surveys, we found that surgeons provided a wide range of responses and used a number of different methods to arrive at their response. Several authors have proposed detailed tech niques for decision making based on published rates of AVM subsequent bleeds. Fisher (9) used Markov analysis to com pare surgical and conservative options for a hypothetical pa tient weighing the factors of age, morbidity and mortality rates, risks of subsequent bleeds, and patient desires. Al though such techniques may be valid, they are complex and may be difficult to use in the clinical setting. Iansek et al. (15) used an annual AVM hemorrhage risk of 1% and a surgical mortality risk of 8 to 10%/ in addition to other predictors, to conclude that conservative management offered less atten dant risk than surgical resection of AVMs, even over the long term. In that report, the authors used a hemorrhage rate lower than that reported in most studies and a surgical mortality rate higher than what could be achieved at most centers during the 1980s. Decision analysis techniques have also been applied to aneurysm data (8, 32).
Risk estimates for AVM hemorrhage are important because of the crucial role they play in guiding treatment. Successful complete microsurgical resection immediately eliminates the long-term risk of hemorrhage (2, 13, 14) . For management options, such as stereotactic radiosurgery (21), endovascular embolization, or staged procedures, a latency interval before obliteration renders mandatory some consideration of the hemorrhage risk. If no treatment (conservative observation) is pursued, then the lifetime risks for AVM hemorrhage and potential mortality must be accepted and understood. We selected a 3% annual risk for Table 1 as a conservative estimate between published data of 2 and 4%.
Because this formula demands that all predicted years act independently (a uniform natural history), the annual hem orrhage risk must be properly interpreted. For discussion, we will assume an annual risk of 3%. A common error is to multiply the 3% risk by the number of years of interest (the method used by many of the neurosurgeons in our survey). For example, a 10-year-old with 70 years of estimated life remaining does not have a 210% chance of lifetime hemor rhage. Luessenhop and Rosa (20) plotted patient age versus percentage probability of bleeding. Although their graph showed a 100% lifetime hemorrhage risk for patients younger than 40 years (which they admitted was incorrect), they plot ted the risk for patients older than 40 years by directly mul tiplying 3% by the number of years remaining (i.e., a 50-yearold living to age 75 has a 75% chance of bleeding). The actual risk calculated by the multiplicative law of probability is 53% (1 -0.9725). This graph was later cited and reprinted in the natural history of AVMs review provided by Wilkins (36).
The application of the multiplicative law of probability is proposed as a simple and reasonable alternative method for AVM hemorrhage risk calculation. A number of assumptions are required in the application of this law and are discussed below.
Assumption 1: population homogeneity
Some degree of population homogeneity has been demon strated by the results of studies performed in different na tions. American (4,11,12), Japanese (16), Swedish (10), French (17), British (6), and Finnish (24) groups provided consistent data on the long-term risk of hemorrhage in untreated pa tients. Although individual patients within a population vary considerably in regard to age, AVM location, size, and hemo dynamic pattern, the presence of associated aneurysms, and systemic physiological states (e.g., pregnancy, coagulopathy), the populations, as a whole, seem to be remarkably uniform. The assumption of overall population homogeneity seems reasonable.
Assumption 2: uniform natural history
To predict hemorrhage risk over the course of a lifetime, this formula assumes that each year of prediction is indepen dent. For this to be true, the annual 3% hemorrhage risk must be applicable to young, middle-aged, and elderly patients; The traditionally held concept that the risk of an AVM hem orrhage is significantly lower in the elderly, does not hold up in reported studies. Although most series indicate a higher rate of clinical presentation at the 20-to 40-year age interval (27), the actual proportion of hemorrhagic to nonhemorrhagic AVM presentations remains fairly constant through the adult years. Parkinson and Bachers (25) studied 100 consecutive patients with brain AVMs and stratified the percentage of hemorrhagic presentations by decade; no significant differ ences were seen. In the study by Ondra et al. (24), with a mean follow-up of 24 years, the hemorrhage rates remained con stant through 5-year stratifications of the first 20 years of the study period (with some decline thereafter), regardless of patient age upon entrance into the study. Pregnancy (7) or hypertension might predispose patients to hemorrhage, but their significance in population risks is low. Robinson et al. (28) found no increase in risk of hemorrhage with increasing gestational age. As noted above, the hemodynamic factor of venous outflow restriction or the presence of proximal or intranidal aneurysms also might increase the risk for hemor rhage and must be identified and considered in individual patients. Although some reports note the occurrence of the spontaneous enlargement or regression of AVMs, this phe nomenon appears to be infrequent enough as to not signifi cantly contribute to a changing natural history (22, 35) .
The risk of hemorrhage in the initial posthemorrhage year was reported by Graf et al. (12) These reported observations do not mean, however, that AVMs in children will present with hemorrhage at a higher rate (e.g., >2-4% /yr) but that those that do, do so with hemorrhage. Because there is evidence that suggests some degree of natural history uniformity across different age groups, we thought this assumption was valid.
For AVMs, all current treatment alternatives mandate an understanding of the natural history of the risk of hemor rhage. Such an understanding is not only important for pa tient education and for comparison to our surgical results but also for the justification of the selection of a specific manage ment strategy. The simplicity of this formula and its appro priateness for most patients with AVMs within the frame work of addressed assumptions makes it a reasonable alternative for physicians who are managing these difficult problems. 
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